Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Navratilova, J. Zatloukal, E. Kriegova, F. Mrazek, V. Kolek, M. Petrek (Olomouc, Czech Republic). MMP2, 8, 9 and TIMP1-4 levels in bronchoalveolar fluid of patients with chronic obstructive pulmonary disease and bronchial asthma. Eur Respir J 2010; 36: Suppl. 54, 1358

Member's Comments

No comment yet.

Related content which might interest you: The expression of MMP2, 9 and TIMP1 mRNA in bronchoalveolar cells of patients with chronic obstructive pulmonary disease (COPD) and bronchial asthma Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009 Is there any correlation between apoptosis of the cells from bronchoalveolar lavage fluid (BALF) and the progression of chronic obstructive pulmonary disease (COPD)? Source: Annual Congress 2011 - COPD mechanisms Year: 2011 CC10 and TIMP1 levels in induced sputum of smokers who developed chronic airflow impairment Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking Year: 2005 Studies on interferon-gamma (IFN-γ) expression in lower airways of patients with idiopathic pulmonary fibrosis (IPF), sarcoidosis and pneumoconioses. Lower IFN-γ levels in bronchoalveolar lavage (BAL) supernatants of IPF subgroup with decrease Source: Eur Respir J 2007; 30: Suppl. 51, 121s Year: 2007 Relationship between MMP-9 and TIMP-1 induced sputum concentration and the stage of chronic obstructive pulmonary disease‘s (COPD) Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008 Changes of TNF-a level in bronchoalveolar fluid of patients with chronic obstructive pulmonary disease before and after the 30 days treatment with tiotropium bromide Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 Levels of CC-chemokines (MCP-1, MIP-1α, MIP-1β) in induced sputum of patients with chronic obstructive pulmonary disease and patients with chronic bronchitis Source: Eur Respir J 2001; 18: Suppl. 33, 194s Year: 2001 Changes of BAL findings as no progression marker in idiopathic pulmonary fibrosis (IPF) patients treated with IFN-g Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases Year: 2006 Lysozyme level and activity are decreased in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and potentially contribute to increased susceptibility to pulmonary infection Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases Year: 2006 Effects of N-acetylcystein on oxidant-antioxidant activity in smokers with chronic obstructive pulmonary disease Source: Annual Congress 2005 - What's new in tobacco and lung disease Year: 2005 Sampling the lung fluids: peripheral biomarkers Source: Annual Congress 2007 - Pulmonary biomarkers in COPD Year: 2007 Expression profiling of Th17 associated molecules in bronchoalveolar cells from patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011 Cellular composition of bronchoalveolar lavage (BAL) as inflammation indicator in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Diagnostic and therapeutic bronchoscopy: old and new techniques for interventional pulmonology Year: 2014 Angiopoietins in sputum supernatant of patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid Source: Eur Respir J 2004; 24: 964-970 Year: 2004 Glycosaminoglycans significantly correlate with matrix metalloproteinases during exacerbations of COPD Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 A study of the level of interleukin-32 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and asthma Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 CCR5 expression and CC-chemokine levels in broncho-alveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2002; 20: Suppl. 38, 598s Year: 2002 Pulmonary and systemic inflammation in patients with AECOPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Relationship between Candida strains colonization and MMP-9 and TIMP-1 induced sputum concentration in chronic obstructive pulmonary disease‘s (COPD) patients and healthy control group Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010